Clinicopathological feature and long-term prognosis of apocrine carcinoma of the breast in Japanese women

Breast Cancer Research and Treatment

Volumn 88, Issue 1, 2004, Pages 49-54

  Takeuchi, Hideya ^a   Tsuji, Kohichi ^a   Ueo, Hiroaki ^a   Kano, Tadashi ^a   Maehara, Yoshihiko ^b  

^a OITA PREFECTURAL HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

apocrine carcinoma; hormone receptor; unilateral multicentric carcinoma

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; APOCRINE CARCINOMA; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; HORMONE RESPONSE; HUMAN; JAPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CANCER; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 8744276682     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-9495-z     Document Type: Review

References (24)

1. Abati AD, Kimmel M, Rosen PP: Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. Am J Clin Pathol 94: 371-377, 1990
2. Moriya T, Sakamoto K, Sasano H et al.: Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Mod Pathol 13: 13-18, 2000
3. Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH: Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61: 1055-1063, 1978
4. Dixon JM, Lumsden AB, Miller WR: The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease. Eur J Cancer Clin Oncol 21: 1047-1050, 1985
5. Durham JR, Fechner RE: The histologic spectrum of apocrine lesions of the breast: Am J Clin Pathol 113: 3-18, 2000
6. Tavassoli FA, Norris HJ. Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases. Mod Pathol 7: 813-818, 1994
7. Leal C, Henrique R, Monteiro P et al.: Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol 32: 487-493, 2001
8. Tominaga S, Kuroishi T: Epidemiology of breast cancer in Japan. Breast Cancer 2: 1-7, 1995
9. Merchant WJ, Millis RR, Smith P, Chaudary MA, Barnes DM: Expression of c-erbB2 and p53 protein is similar in breast cancer from British and Japanese women. Int J Cancer 84: 278-283, 1999
10. Matsuo K, Fukutomi T, Tsuda H, Kanai Y, Tanaka SA, Nanasawa T: Apocrine carcinoma of the breast: clinicopathological analysis and histological subclassification of 12 cases. Breast Cancer 5: 279-284, 1998
11. Matsuo K, Fukutomi T, Hasegawa T, Akashi-Tanaka S, Nanasawa T, Tsuda H: Histological and immunohistochemical analysis of apocrine breast carcinoma. Breast cancer 9: 43-49, 2002
12. Fu L, Tsuchiya S, Matsuyama I, Ishii K: Clinicopathologic features and incidence of invasive lobular carcinoma in Japanese women. Pathol Int 48: 348-354, 1998
13. Gilles R, Lesnik A, Guinebretiere JM et al.: Apocrine carcionoma: clinical and mammographie features. Radiology 190: 495-497, 1994
14. Bratthauer GL, Lininger RA, Man YG, Tavassoli FA: Androgen and estrogen receptor mRNA status in apocrine carcinomas. Diagn Mol Pathol 11: 113-118, 2002
15. Gatalica Z: Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract 193: 753-758, 1997
16. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR: Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med 130: 270-277, 1999
17. Gilchrist KW, Gould VE, Hirschl S et al.: Interobserver variation in the identification of breast carcinomas in intramammary lymphatics. Hum Pathol 13: 170-172, 1982
18. de Mascarel I, Bonichon F, Durand M et al.: Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. Eur J Cancer 34: 58-65, 1998
19. Lauria R, Perrone F, Carlomagno C et al.: The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 76: 1772-1778, 1995
20. Weigand RA, Isenberg WM, Russo J, Brennan MJ, Rich MA: Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer. Cancer 50: 962-969, 1982
21. Hasebe T, Sasaki S, Imoto S, Ochiai A: Histological characteristic of tumors in blood vessels play an important role in tumor progression of invasive ductal carcinoma of the breast. Cancer Sci 94: 158-165, 2003
22. Nagy JA, Brown LF, Senger DR et al.: Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948: 305-326, 1989
23. McBoyle MF, Razek HA, Carter JL, Helmer SD: Tubular carcinoma of the breast: an institutional review. Am Surg 63: 639-644, 1997
24. Lesser ML, Rosen PP, Kinne DW: Multicentricity and bilaterality in invasive breast carcinoma. Surgery 91: 234-240, 1982